Dysregulated calcium homeostasis and oxidative stress in chronic myeloid leukemia (CML) cells

Journal of Cellular Physiology

Volumn 224, Issue 2, 2010, Pages 443-453

  Ciarcia, Roberto ^a   D'Angelo, Danila ^a   Pacilio, Carmen ^b   Pagnini, David ^c   Galdiero, Massimiliano ^a   Fiorito, Filomena ^a   Damiano, Sara ^a   Mattioli, Eliseo ^e   Lucchetti, Chiara ^d   Florio, Salvatore ^a   Giordano, Antonio ^d,e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c ASL Caserta (CE)   (Italy)

^d Temple University   (United States)

^e UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; IONOMYCIN; MALONALDEHYDE; RESVERATROL; SUPEROXIDE DISMUTASE; NITRIC OXIDE; STILBENE DERIVATIVE;

ADULT; AGED; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL; LEUKOCYTE; MALE; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; BIOSYNTHESIS; DRUG EFFECT; HOMEOSTASIS; INTRACELLULAR SPACE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADENOSINE TRIPHOSPHATE; ADULT; CALCIUM; FEMALE; HOMEOSTASIS; HUMANS; INTRACELLULAR SPACE; IONOMYCIN; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; STILBENES; SUPEROXIDE DISMUTASE;

EID: 77953624006     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22140     Document Type: Article

References (62)

1. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. 2004. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res 24:2783-2840. (Pubitemid 39409568)
2. Arnold RS, Shi J, Murad E, Whalen AM, Sun CQ, Polavarapu R, Parthasarathy S, Petros JA, Lambeth JD. 2001. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc Natl Acad Sci USA 98:5550-5555.
3. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG. 1997. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272:217-221.
4. Bass DA, Dechatelet LR, McCall CE. 1978. Independent stimulation of motility and the oxidative metabolic burst of human polymorphonuclear leukocytes. J Immunol 121:172-178.
5. Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ. 1994. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83:2038-2044. (Pubitemid 24112713)
6. Berridge MJ. 1995. Calcium signalling and cell proliferation. BioEssays 17:491-500.
7. Bours MJL, Swennen ELR, Di Virgilio F, Cronstein BN, Dagnelie PC. 2006. Adenosine 5′-triphosphate and adenosine as endogenous signalling molecules in immunity and inflammation. Pharmacol Ther 112:358-404.
8. Buggin AGS, Milojkovic D, Arno MJ, Lea NC, Mufti GJ, Shaun N, Thomas B, Hirst WJR. 2001. Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-κB, c-Myc, and pRb pathways. J Immunol 167:6021-6030.
9. Caroline J, Morimoto RI. 2000. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 92:1564-1572.
10. Chakraborty PK, Mustafi SB, Ganguly S, Chatterjee M, Raha S. 2008. Resveratrol induces apoptosis in K562 (chronicmyelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70. Cancer Sci 99:1109-1116.
11. Chandler LJ, Kopniscky K, Richards E, Crews FT, Summers C. 1995. Angiotensin II decreases inducible nitric oxide synthase expression in rat astroglial cultures. Am J Physiol 268:C700-C707.
12. i) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
13. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S. 1988. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92:996-1002.
14. Dai Z, Quackenbush RC, Courtney KD, Grove M, Cortez D, Reuther GW, Pendergast AM. 1998. Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes Dev 12:1415-1424.
15. Deininger MWN, Goldman JM, Melo JV. 2000. The molecular biology of chronic myeloid leukaemia. Blood 96:3343-3356.
16. Demidchik V, Nichols C, Oliynyk M, Dark A, Glover BJ, Davies JM. 2003. Is ATP a signaling agent in plants? Plant Physiol 133:456-461.
17. Dobrydneva Y, Williams LR, Blackmore PF. 1999. trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets. Br J Pharmacol 28:149-157. (Pubitemid 29425279)
18. Esterbauer H, Cheeseman KH. 1990. Determination of aldhehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407-421. (Pubitemid 20279982)
19. Florio S, Ciarcia R, Crispino L, Pagnini U, Ruocco A, Kumar C, D'Andrilli G, Russo F. 2003. Hydrocortisone has a protective effect on CyclosporinA-induced cardiotoxicity. J Cell Phys 1:21-26. (Pubitemid 36292756)
20. Fulda S, Debatin KM. 2006. Resveratrol modulation of signal transduction in apoptosis and cell survival: A mini-review. Cancer Detect Prev 30:217-223. (Pubitemid 44163050)
21. Gao X, Xu YX, Divine G, Janakiraman N, Chapman RA, Gautam SC. 2002. Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J Nutr 132:2076-2081. (Pubitemid 34742903)
22. 2+ entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol 280:H746-H755.
23. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF. 1987. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 328:342-344.
24. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
25. Gupta A, Rosenberger SF, Bowden GT. 1999. Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines. Carcinogenesis 20:2063-2073.
26. Hassan-Khabbaar S, Cottart CH, Wendum D, Vibert F, Clot JP, Savouret JF, Conti M, Nivet-Antoine V. 2008. Postischemic treatment by trans-resveratrol in rat liver ischemia-reperfusion: A possible strategy in liver surgery. Liver Transpl 14:451-459.
27. Hennings H, Michael D, Cheng C, Steinen D, Holbrook K, Yuspa SH. 1980. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 79:245-254. (Pubitemid 10154229)
28. Jackson AL, Loeb LA. 2001. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 477:7-21.
29. Kato M, Minakami H, Kuroiwa M, Kobayashi Y, Oshima S, Kozawa K, Morikawa A, Kimura H. 2003. Superoxide radical generation and Mn- and Cu-Zn superoxide dismutases activities in human leukemic cells. Hematol Oncol 21:11-16. (Pubitemid 36356240)
30. Kretsinger RH. 1979. The informational role of calcium in the cytosol. Adv Cyclic Nucleotide Res 11:1.
31. Lewis RS. 2001. Calcium signalling mechanisms in T lymphocytes. Annu Rev Immunol 19:497-521.
32. 2+ spike frequency can optimize gene expression. Nature 30:936-941.
33. Li-Jun Y, Mo-Li W, Hong L, Xiao-Yan C, Qian W, Yuan S, Qing-You K, Jia L. 2008. Inhibition of STAT3 expression and signalling in resveratrol- differentiated medulloblastoma cells. Neoplasia 10:736-744.
34. 2+ oscillation frequency regulates agonist-stimulated gene expression in vascular endothelial cells. J Cell Sci 121:2511-2518.
35. Ljchtman AH, Segel GB, Uchtman MA. 1983. The role of calcium in lymphocyte proliferation. Blood 67:413-422.
36. Lowry OH, Rosembrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
37. 2+ and mCICR-mediated MPT activation in HepG2 cells. Mol Cell Biochem 302:99-109.
38. 2+ influx following receptor activation. Trends Pharmacol Sci 12:289-292.
39. Murrell GA, Francis MJ, Bromley L. 1990. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 265:659-665. (Pubitemid 20053867)
40. Ozkan OV, Yuzbasioglu MF, Ciralik H, Kurutas EB, Yonden Z, Aydin M, Bulbuloglu E, Semerci E, Goksu M, Atli Y, Bakan V, Duran N. 2009. Resveratrol, a natural antioxidant, attenuates intestinal Ischemia/reperfusion injury in rats. Tohoku J Exp Med 218:251-258.
41. Pagnini U, Pacilio C, Florio S, Crispino A, Claudio PP, Giordano A, Pagnini G. 2000. Medroxyprogesterone acetate increases anthracyclines uptake in chronic lymphatic leukaemia cells: Role of nitric oxide and lipid peroxidation. Anticancer Res 20:33-42. (Pubitemid 30189731)
42. Parekh AB, Putney JW, Jr. 2005. Store-operated calcium channels. Physiol Rev 85:757-810.
43. Piwocka K, Vejda S, Cotter TG, O'Sullivan GC, McKenna SL. 2006. BCR/ABL reduces endoplasmic reticulum releasable calcium levels by a BCL-2-indepandent mechanism and inhibits calcium-dependent apoptotic signalling. Blood 107:4003-4010. (Pubitemid 43726808)
44. Pluthero FG, Axelrad AA. 1991. Superoxide dismutase as an inhibitor of erythroid progenitor cell cycling. Ann NY Acad Sci 628:222-232.
45. Putney JW, Jr. 1986. A model for receptor-regulated calcium entry. Cell Calcium 7:1-12.
46. Putney JW, Jr. 1990. Capacitative calcium entry revisited. Cell Calcium 11:611-624.
47. Putney JW, Jr., Broad LM, Braun FJ, Lievremont JP, Bird GS. 2001. Mechanisms of capacitative calcium entry. J. Cell Sci 114:2223-2229.
48. Rasmussen H, Goodman DB. 1977. Relationships between calcium and cyclic nucleotides in cell activation. Physiol Rev 57:421. (Pubitemid 8154767)
49. Roche E, Prentki M. 1994. Calcium regulation of immediate-early response genes. Cell Calcium 16:331-338. (Pubitemid 24300844)
50. Sawyers CL. 1999. Chronic myeloid leukaemia. N Engl J Med 340:1330-1340.
51. Sugioka M, Yamashita M. 2003. Calcium signalling to nucleus via store-operated system during cell cycle in retinal neuroepithelium. Neurosci Res 45:447-458. (Pubitemid 36349102)
52. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD. 1999. Cell transformation by the superoxide- generating oxidase Mox1. Nature 401:79-82. (Pubitemid 29418446)
53. Sun VI, Larry W, Oberley Ving U. 1988. A simple method for clinical assay of superoxide dismutase. Clin Chem 34/3:497-500.
54. 2 for platelet-derived growth factor signal transduction. Science 270:296-299.
55. Szatrowski TP, Nathan CF. 1991. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51:794-798.
56. 2+ pool depletion in thapsigargin resistant cells. J Biol Chem 272:6440-6447.
57. Wang Q, Li H, Wang XW, Wu DC, Chen XY, Liu J. 2003. Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells. Neurosci Lett 351:83-86. (Pubitemid 37329594)
58. Weiss H, Amberger A, Widschwendter M, Margreiter R, Ofner D, Dietl P. 2001. Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of nonsteroidal anti-inflammatory drugs in human colon cancer cells. Int J Cancer 92:877-882. (Pubitemid 32471861)
59. Whitaker M, Patel R. 1990. Calcium and cell cycle control. Development 108:525-542.
60. Wiley SJ, Dubyak GR. 1989. Extracellular adenosine triphosphate increases cation permeability of chronic lymphocytic leukemic lymphocytes. Blood 73:1316-1323.
61. Zhang LP, Yin JX, Liu Z, Zhang Y, Wang QS, Zhao J. 2006. Effect of resveratrol on L-type calcium current in rat ventricular myocytes. Acta Pharmacol Sin 27:179-183. (Pubitemid 43171156)
62. 2+ channels and T-lymphocyte activation by the pyrazole derivative BTP-2. J Biol Chem 279:12427-12437.